• Item #: ZH206-
  * Marked fields are required.
Price $160.00
Confirmation of active Lyme disease Monitoring Lyme disease treatment PCR testing should be limited
to patients with a positive, or at least an equivocal, serologic test for antibody to Borrelia burgdorferi,
mayonii, garinii or afzelii. Lyme disease is a multisystem and multistage infection caused by 3 species of
tick-borne spirochetes in the Borrelia burgdorferi sensu lato genogroup. These spirochetes include
Borrelia burgdorferi sensu stricto (North America and Western Europe), Borrelia afzelii (Central and
Western Europe and Russia), and Borrelia garinii (Europe, Russia, and northern Asia). Endemic areas for
Lyme disease in the United States correspond with the distribution of 2 tick species, Ixodes dammini
(Northeastern and Upper Midwestern US) and Ixodes pacificus (West Coast US). In Europe, Ixodes
ricinus transmits the spirochete.